93 results
Page 3 of 5
8-K
EX-10.2
e2nz6zv0gsr 19
2 May 22
Departure of Directors or Certain Officers
4:07pm
8-K
EX-99.1
c1siut3nxz3br 2xuts
8 Mar 22
Magenta Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Highlights
8:26am
8-K
EX-99.1
95g6rmn9 76qe7
10 Jan 22
Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022
8:15am
8-K
EX-99.1
ag8tf9 nb1brnv
11 Jan 21
Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials
8:16am
424B5
cba0bujzj
25 Jun 20
Prospectus supplement for primary offering
5:11pm
424B5
31zs0jqphn 2jwh
24 Jun 20
Prospectus supplement for primary offering
5:29pm